Nobilis Health Corp.
NRTSF · OTC
6/30/2018 | 3/31/2018 | 12/31/2017 | 9/30/2017 | |
|---|---|---|---|---|
| Revenue | $69,189 | $64,457 | $86,801 | $64,652 |
| % Growth | 7.3% | -25.7% | 34.3% | – |
| Cost of Goods Sold | $26,688 | $26,142 | $30,503 | $26,121 |
| Gross Profit | $42,501 | $38,315 | $56,298 | $38,531 |
| % Margin | 61.4% | 59.4% | 64.9% | 59.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $33,163 | $35,309 | $33,555 | $34,439 |
| SG&A Expenses | $33,163 | $35,309 | $33,555 | $34,439 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,180 | $1,851 | $6,762 | -$143 |
| Operating Expenses | $38,371 | $40,034 | $37,120 | $37,248 |
| Operating Income | $4,130 | -$2,750 | $16,776 | $1,283 |
| % Margin | 6% | -4.3% | 19.3% | 2% |
| Other Income/Exp. Net | -$1,895 | -$1,095 | $4,827 | -$1,352 |
| Pre-Tax Income | $2,235 | -$3,845 | $21,603 | -$69 |
| Tax Expense | $495 | -$704 | $12,372 | -$70 |
| Net Income | $885 | -$3,852 | $3,596 | $1,014 |
| % Margin | 1.3% | -6% | 4.1% | 1.6% |
| EPS | 0.01 | -0.049 | 0.05 | 0.01 |
| % Growth | 120.3% | -198.6% | 400% | – |
| EPS Diluted | 0.01 | -0.049 | 0.05 | 0.01 |
| Weighted Avg Shares Out | 78,186 | 78,184 | 77,994 | 77,805 |
| Weighted Avg Shares Out Dil | 82,154 | 78,184 | 78,249 | 78,132 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,292 | $2,885 | $2,009 | $1,380 |
| Depreciation & Amortization | $5,208 | $4,725 | $3,565 | $2,809 |
| EBITDA | $9,338 | $3,765 | $20,641 | $4,092 |
| % Margin | 13.5% | 5.8% | 23.8% | 6.3% |